These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting. Jia Y; Shi W; Zhou Z; Wagh NK; Fan W; Brusnahan SK; Garrison JC Nucl Med Biol; 2015 Nov; 42(11):816-23. PubMed ID: 26302836 [TBL] [Abstract][Full Text] [Related]
6. (18)F- and (68)Ga-Labeled Neurotensin Peptides for PET Imaging of Neurotensin Receptor 1. Maschauer S; Einsiedel J; Hübner H; Gmeiner P; Prante O J Med Chem; 2016 Jul; 59(13):6480-92. PubMed ID: 27336295 [TBL] [Abstract][Full Text] [Related]
7. Improved radiosynthesis and preliminary in vivo evaluation of a (18)F-labeled glycopeptide-peptoid hybrid for PET imaging of neurotensin receptor 2. Maschauer S; Greff C; Einsiedel J; Ott J; Tripal P; Hübner H; Gmeiner P; Prante O Bioorg Med Chem; 2015 Jul; 23(14):4026-33. PubMed ID: 25691211 [TBL] [Abstract][Full Text] [Related]
8. Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors. García-Garayoa E; Maes V; Bläuenstein P; Blanc A; Hohn A; Tourwé D; Schubiger PA Nucl Med Biol; 2006 May; 33(4):495-503. PubMed ID: 16720241 [TBL] [Abstract][Full Text] [Related]
12. Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor. Wu Z; Li L; Liu S; Yakushijin F; Yakushijin K; Horne D; Conti PS; Li Z; Kandeel F; Shively JE J Nucl Med; 2014 Jul; 55(7):1178-84. PubMed ID: 24854793 [TBL] [Abstract][Full Text] [Related]
13. 1,4-Disubstituted 1,2,3-Triazoles as Amide Bond Surrogates for the Stabilisation of Linear Peptides with Biological Activity. Rečnik LM; Kandioller W; Mindt TL Molecules; 2020 Aug; 25(16):. PubMed ID: 32781656 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors. García-Garayoa E; Allemann-Tannahill L; Bläuenstein P; Willmann M; Carrel-Rémy N; Tourwé D; Iterbeke K; Conrath P; Schubiger PA Nucl Med Biol; 2001 Jan; 28(1):75-84. PubMed ID: 11182567 [TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc. García-Garayoa E; Bläuenstein P; Bruehlmeier M; Blanc A; Iterbeke K; Conrath P; Tourwé D; Schubiger PA J Nucl Med; 2002 Mar; 43(3):374-83. PubMed ID: 11884498 [TBL] [Abstract][Full Text] [Related]